VARGOVÁ, Karin, Nikola CURIK, Pavel BURDA, Petra BAŠOVÁ, Vojtěch KULVAIT, Vít POSPÍŠIL, Filipp SAVVULIDI, Juraj KOKAVEC, Emanuel NEČAS, Adéla BERKOVÁ, Petra OBRTLÍKOVÁ, Josef KARBAN, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Marek TRNĚNÝ, Jiří ZAVADIL and Tomáš STOPKA. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood. Washington, DC , USA: American Society of Hematology, 2011, vol. 117, No 14, p. 3816-3825. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2010-05-285064.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
Name in Czech MYB transkripčně reguluje miR-155 gen u chronické lymfatické leukémie
Authors VARGOVÁ, Karin (203 Czech Republic), Nikola CURIK (203 Czech Republic), Pavel BURDA (203 Czech Republic), Petra BAŠOVÁ (203 Czech Republic), Vojtěch KULVAIT (203 Czech Republic), Vít POSPÍŠIL (203 Czech Republic), Filipp SAVVULIDI (203 Czech Republic), Juraj KOKAVEC (203 Czech Republic), Emanuel NEČAS (203 Czech Republic), Adéla BERKOVÁ (203 Czech Republic), Petra OBRTLÍKOVÁ (203 Czech Republic), Josef KARBAN (203 Czech Republic), Marek MRÁZ (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution), Marek TRNĚNÝ (203 Czech Republic), Jiří ZAVADIL (203 Czech Republic) and Tomáš STOPKA (203 Czech Republic, guarantor).
Edition Blood, Washington, DC , USA, American Society of Hematology, 2011, 0006-4971.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 9.898
RIV identification code RIV/00216224:14740/11:00056976
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1182/blood-2010-05-285064
UT WoS 000289265500017
Keywords in English MYB; CLL; miR-155 host gene; B-CLL
Tags ok, rivok
Tags International impact
Changed by Changed by: Olga Křížová, učo 56639. Changed: 9/4/2012 16:15.
Abstract
Elevated levels of microRNA miR-155 represent a candidate pathogenic factor in chronic B-lymphocytic leukemia (B-CLL). In this study, we present evidence that MYB (v-myb myeloblastosis viral oncogene homolog) is overexpressed in a subset of B-CLL patients. MYB physically associates with the promoter of miR-155 host gene (MIR155HG, also known as BIC, B-cell integration cluster) and stimulates its transcription. This coincides with the hypermethylated histone H3K4 residue and spread hyperacetylation of H3K9 at MIR155HG promoter. Our data provide evidence of oncogenic activities of MYB in B-CLL that include its stimulatory role in MIR155HG transcription.
Abstract (in Czech)
Zvýšené množství microRNA miR-155 representuje kandidátní patogenetický faktor u chronické lymfatické leukémie. V této studii demonstrujeme, že MYB (v-myb myeloblastosis viral oncogene homolog) je zvýšeně exprimován u subtypu CLL paciemtů. MYB je fyzicky asociován s promotorem genu obsahujícího miR-155 (MIR155HG, také znám jako BIC) a stimuluje jeho transkripci.
Links
NT11218, research and development projectName: Funkční a strukturní změny microRNA u lymfoproliferativních malignit a jejich vliv na prognózu onemocnění a predikci léčebné odpovědi
PrintDisplayed: 4/8/2024 22:14